← European Medicine Shortage Tracker · all medicines
Ustekinumab spain currently has availability issues reported in 1 European register: Greece.
Limited availability ATC L04AC05 · also listed as: USTEKINUMAB SPAIN · data refreshed 11 August 2026
As of 11 August 2026, 1 of the 10 tracked registers list current availability issues for Ustekinumab spain, covering 1 affected product presentation. The longest-running open report was filed in Greece on 2026-06-19 and has now been open for about 2 months. Notably, 1 report has already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. Registers in Greece indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Ustekinumab spain is coded L04AC05 — a medicine acting on antineoplastic and immunomodulating agents — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇬🇷 Greece | Limited availability IMULDOSA C/S.SOL.IN 130MG/26ML (5MG/ML) BT X 1 VIAL | 2026-06-19 | 2026-07-20 | Ποιοτικό πρόβλημα - Συσκευασία περιεκτικότητας LENALIDOMIDE ACCORD CAP Alternatives: Προβλήματα στην παραγωγική Εναλλακτικά άλλα σκευάσματα της ίδιας δραστικής, μορφής και | register ↗ |
Every individual register entry for Ustekinumab spain in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇬🇷 GR | IMULDOSA C/S.SOL.IN 130MG/26ML (5MG/ML) BT X 1 VIAL | Limited availability | 2026-06-19 | 2026-07-20 | Ποιοτικό πρόβλημα - Συσκευασία περιεκτικότητας LENALIDOMIDE |
Yes. As of 11 August 2026, availability issues are reported in: Greece. Availability is national — a shortage in one country does not mean it is short everywhere.
1 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency register that lists Ustekinumab spain: EOF limited-availability list (Greece). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Ustekinumab spain — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/ustekinumab-spain/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Ustekinumab spain availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/ustekinumab-spain/">Ustekinumab spain shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>